Skip to page content

Summary

Cell Manufacturing Technologies, or CMaT, applies an engineering perspective to health care. Specifically, this project aims to treat cancer by producing a virus, extracting a patient's T-cells, infecting the T-cells with the virus and then infusing them back into the patient to act as "warriors" against cancer cells. By taking an engineering tact, scientists are researching production and replication methods to support cancer treatment options.

This award comes from the Georgia Institute of Technology, which received the original grant. Several units at the University of Georgia are involved led by Steven Stice, professor, senior research scientist and eminent scholar in the UGA College of Agricultural and Environmental Sciences, to help carry out the mission of this grant.

In the College of Education, professor Cory Buxton is developing K-12 and college-level lesson plans to introduce the concepts behind CMaT, known as bioengineering, to students at all levels. Buxton is also coordinating summer research experiences for college students and high school science teachers. Through these programs, students will learn more about bioengineering while teachers will get hands-on experience with the concepts that support it. With a need for a growing workforce in the future, Buxton is helping to lay the groundwork now to meet that need in the future.

Sponsorship

National Science Foundation
$3,064,501

Principal Investigator

Steven Stice

Co-PIs

Key Investigator

Active Since

October 2017